REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFusion Antibody Share News (FAB)

Share Price Information for Fusion Antibody (FAB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.40
Bid: 3.30
Ask: 3.50
Change: 0.00 (0.00%)
Spread: 0.20 (6.061%)
Open: 3.40
High: 3.40
Low: 3.40
Prev. Close: 3.40
FAB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Sondrel wins USD23 million contract

Tue, 27th Feb 2024 14:18

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

----------

Cloudbreak Discovery PLC - Vancouver, Canada-based natural resource project generator - Signs an exploration agreement for the acquisition of its proprietary database of lithium targets in Texas. Smackover Resources LLC, a wholly owned subsidiary of Lonestar Lithium Inc, has purchased the proprietary database with regional modelling and data compilation across eastern Texas from Cloudbreak. The terms include: 2.0 million shares in Lonestar; USD25,000 each time a Qualifying Transaction property is generated from the database; and 0.5% Royalty produced lithium on each Qualifying Transaction property. The areement is for three years. Interim Chief Executive Andrew Male says: "This Exploration Agreement is a good example of the type of transactions Cloudbreak has completed in the past and will continue to do with a sector of its asset base. It took considerable time and effort to compile this database and being able to sell this on to Lonestar demonstrates the possible valuation accretion by doing this type of business."

----------

United Oil & Gas PLC - Oil and gas company, focused on Egypt, the UK and Jamaica - Raises GBP1.0 million through oversubscribed placing of 457.5 million shares and 42.5 shares by way of a subscription. A total of 500.0 million shares will be issued through the fundraising, 76% of the company's issued share capital. Funds will be used to progress work in Jamaica and for administration costs.

----------

Diaceutics PLC - Belfast-based provider of diagnostic commercialisation services to pharmaceutical and biotechnology companies - Expands its data supply network, which it says will significantly increase the number of labs through which Diaceutics is sourcing data in Europe and will broaden the company's European data coverage. This data will accelerate the rollout of the DxRx Signal product in key EU markets of Germany, France, Italy, Spain and the UK. Jordan Clark, chief data officer of Diaceutics, comments: "This data will further endorse our position as a leading provider of data to biotech and pharma companies as they commercialize their products, find and deliver therapies to patients across multiple geographies."

----------

Crossword Cybersecurity PLC - London-based cybersecurity solutions provider - Launches Trillion HarVista. Says the Trillion HarVista tool allows enterprise security teams to search conversations on the dark web in a clean and sanitised environment. It "enables security teams, for the first time, to be able to identify the threats developing both from hacker discussions and shared compromised credential data all from a single interface, without the risk of searches on hostile websites being linked to your organisation."

----------

Fusion Antibodies PLC - Belfast-based contract researcher, which provides discovery, design and optimisation services for therapeutic antibodies to the healthcare market - Receives a first purchase order under the master services agreement with an unnamed "leading diagnostics company." The first purchase order, valued at around GBP60,000, has been received for an initial project to generate antibodies specifically for the client's use in diagnostic products. It is anticipated that further purchase orders will follow for additional and recurring projects. CEO Adrian Kinkaid says: "Reaching this agreement with a world class diagnostics provider positively reinforces the value to the wider commercial world of Fusion Antibodies' technologies and capabilities. In this case it is the generation of antibodies in diagnostics products. We look forward to establishing a long-term relationship with our new partner and providing them with assistance to generate better antibodies which are more manufacturable and can be rapidly deployed in clinical diagnostic products for the benefit patient well-being across the globe."

----------

Sondrel Holdings PLC - Reading, England-based semiconductor design services firm - Wins new design and supply contract for a next generation video processing chip with a total estimated value of USD23 million across the design, qualification and projected production life of the product. "The complex chip is to be used for high performance professional video streaming solutions. The company has entered into the master agreement with the customer and design work has commenced whilst the parties finalise negotiations to the exhibits to the agreement," it says. The initial contract value is for over USD9 million for the duration of the design and qualification phases and the work will be fully funded by the customer. CEO Graham Curren says: "This is a substantial design and supply contract for Sondrel and a demonstration of the group's ability to provide the most complex engineering expertise required for these next generation technologies. We're delighted to partner with one of the leading manufacturers in the high growth video streaming market, where the constant innovation and focus on efficiency is driving demand for complex chips like Sondrel's." Also reports that it has received four new orders in 2024 year to date for its design consulting services, engaging with two existing customers and two new customers. These contracts will generate a combined revenue of USD900,000 in the current financial year.

----------

By Sophie Rose, Alliance News senior reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.

More News
28 Nov 2023 10:33

AIM WINNERS & LOSERS: Totally swings to half-year loss on NHS blow

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday.

Read more
9 Nov 2023 12:54

EARNINGS AND TRADING: Wincanton profit down; James Cropper ups payout

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
29 Sep 2023 21:19

EARNINGS: Tan Delta revenue jumps; Kendrick Resources loss widens

(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Friday and not separately reported by Alliance News:

Read more
24 Aug 2023 14:45

Fusion Antibodies appoints interim finance chief

(Sharecast News) - Preclinical antibody developer Fusion Antibodies announced the immediate appointment of Stephen Smyth as its interim chief financial officer on Thursday.

Read more
24 Aug 2023 12:10

IN BRIEF: Fusion Antibodies appoints part-time CFO on cash struggles

Fusion Antibodies PLC - Belfast-based contract research organisation providing discovery, design and optimisation services for therapeutic antibodies to the healthcare market - Appoints Stephen Smyth as interim chief financial officer with immediate effect. Smyth was previously CFO at Sera Global LP, and has held senior finance positions at Cormark Securities Inc and PricewaterhouseCoopers LLP. He is currently a partner at FPM Accountants Ltd.

Read more
21 Aug 2023 13:43

Fusion Antibodies progresses AI antibody collaboration

(Sharecast News) - Preclinical antibody discovery specialist Fusion Antibodies updated the market on its 'AI/ML-Ab', or AIM-Lab, service on Monday.

Read more
21 Aug 2023 10:29

AIM WINNERS & LOSERS: Fulcrum Utility to leave AIM as loss widens

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.

Read more
21 Aug 2023 09:35

Fusion Antibodies inks deal with AI learning firm, hails lower costs

(Alliance News) - Fusion Antibodies PLC on Monday said it signed an agreement with an unnamed artificial intelligence & machine learning company, which it said could cut costs per sequence test significantly.

Read more
14 Aug 2023 08:41

Fusion Antibodies completes "difficult" restructuring

(Alliance News) - Fusion Antibodies PLC on Monday said it has completed its restructuring plans, in hopes of reducing annualised costs by about GBP2.2 million.

Read more
1 Jun 2023 15:52

UK shareholder meetings calendar - next 7 days

Friday 2 June 
Cap-XX LtdGM re fundraising
Conduity Capital PLCGM re future direction of the company
Kibo Energy PLCEGM re renewal of director authorisations to issue shares
Mirriad Advertising PLCGM re new ordinary shares admitted to trading on AIM
Purplebricks Group PLCGM re proposed sale of business & assets to Strike Ltd
Monday 5 June 
EnQuest PLCAGM
Tuesday 6 June 
Billington Holdings PLCAGM
Mast Energy Developments PLCAGM
NB Global Monthly Income Fund LtdAGM
Tasty PLCAGM
WANdisco PLCGM re new shares authorisation and fundraise
Wednesday 7 June 
City Pub Group PLCAGM
Gem Diamonds LtdAGM
Gulf Marine Services PLCAGM
Hostmore PLCAGM
LXi REIT PLCAGM
Pennant International Group PLCAGM
Third Point Investors LtdAGM
United Oil & Gas PLCAGM
Xpediator PLCGM re takeover by DLM Bidco
Thursday 8 June 
Ashtead Technology Holdings PLCAGM
Camellia PLCAGM
Checkit PLCAGM
Churchill China PLCAGM
CRH PLCCourt Meeting and EGM re proposal to transfer the company's primary listing to NYSE
Downing Renewables & Infrastructure Trust PLCAGM
Fair Oaks Income LtdAGM
Fusion Antibodies PLCGM re result of retail offer
Genflow Biosciences PLCAGM
Glenveagh Properties PLCAGM
Kavango Resources PLCAGM
Kosmos Energy LtdAGM
Melrose Industries PLCAGM
North American Income Trust PLCAGM
Oriole Resources PLCAGM
Panther Metals PLCAGM
REA Holdings PLCAGM
Renalytix PLCGM re director's authorization to allot new shares and equity securities for cash
Vaalco Energy IncAGM
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
19 May 2023 11:43

IN BRIEF: Fusion Antibodies shares drop after placing at 84% discount

Fusion Antibodies PLC - Belfast-based contract research organisation providing discovery, design and optimisation services for therapeutic antibodies to the healthcare market - Raises GBP1.6 million through a placing and director subscription of 31.2 million shares at 5 pence per share, which is an 84% discount to the stock's close on Thursday of 32.06p. The placing is run by broker Allenby Capital Ltd. Fusion also launches a separate retail offer via the REX platform of up to 10.0 million shares at the same price, to raise up to an additional GBP500,000.

Read more
21 Mar 2023 10:58

Fusion Antibodies files patent application for cancer treatment

(Alliance News) - Fusion Antibodies PLC on Tuesday said it has filed a patent application for a panel of antibodies that bind to an important target for cancer therapeutics.

Read more
6 Mar 2023 16:26

Contract suspensions see Fusion Antibodies warn on revenue

(Sharecast News) - Contract research organisation Fusion Antibodies issued a revenue warning on Monday, after a "challenging" first six months of trading as a number of valuable projects were suspended by clients due to delayed investment.

Read more
6 Mar 2023 12:16

LONDON MARKET MIDDAY: Mining stocks weigh on blue-chip index

(Alliance News) - Stock prices in London were largely lower at midday on Monday, with the FTSE 100 trading in the red, weighed down by poor performances by mining stocks.

Read more
6 Mar 2023 10:52

Fusion Antibodies drops as annual revenue seen significantly lower

(Alliance News) - Fusion Antibodies PLC on Monday said it expects annual revenue to be significantly below expectations as a result of continued uncertainty in the timings of orders.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.